- Home
- RXRX vs LKFT Comparison
RXRX vs LKFT Comparison
Compare RXRX & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RXRX | LKFT |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | Belgium |
| Employees | N/A | 452 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RXRX | LKFT |
|---|---|---|
| Price | $3.79 | $30.37 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 20.6M | 147.0K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $74,681,000.00 | N/A |
| Revenue This Year | $12.11 | N/A |
| Revenue Next Year | $82.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.77 | $28.00 |
| 52 Week High | $7.18 | $30.31 |
Technical Indicators
Market Signals| Indicator | RXRX | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 63.92 | 77.13 |
| Support Level | $2.88 | N/A |
| Resistance Level | $4.01 | N/A |
| Average True Range (ATR) | 0.22 | 0.63 |
| MACD | 0.06 | 0.13 |
| Stochastic Oscillator | 73.18 | 94.74 |
Price Performance
Historical ComparisonAbout RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
About LKFT Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.